rs148404628

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_006612.6(KIF1C):​c.1751-7T>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0088 in 1,604,314 control chromosomes in the GnomAD database, including 82 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0070 ( 9 hom., cov: 32)
Exomes 𝑓: 0.0090 ( 73 hom. )

Consequence

KIF1C
NM_006612.6 splice_region, intron

Scores

2
Splicing: ADA: 0.002009
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.408

Publications

1 publications found
Variant links:
Genes affected
KIF1C (HGNC:6317): (kinesin family member 1C) The protein encoded by this gene is a member of the kinesin-like protein family. The family members are microtubule-dependent molecular motors that transport organelles within cells and move chromosomes during cell division. Mutations in this gene are a cause of spastic ataxia 2, autosomal recessive. [provided by RefSeq, May 2014]
KIF1C-AS1 (HGNC:40324): (KIF1C antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 17-5020485-T-A is Benign according to our data. Variant chr17-5020485-T-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 385057.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00705 (1073/152274) while in subpopulation NFE AF = 0.0111 (757/68006). AF 95% confidence interval is 0.0105. There are 9 homozygotes in GnomAd4. There are 499 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 9 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KIF1CNM_006612.6 linkc.1751-7T>A splice_region_variant, intron_variant Intron 19 of 22 ENST00000320785.10 NP_006603.2
KIF1CXM_005256424.3 linkc.1751-7T>A splice_region_variant, intron_variant Intron 20 of 23 XP_005256481.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KIF1CENST00000320785.10 linkc.1751-7T>A splice_region_variant, intron_variant Intron 19 of 22 1 NM_006612.6 ENSP00000320821.5
KIF1C-AS1ENST00000438266.2 linkn.358+284A>T intron_variant Intron 2 of 3 2
KIF1CENST00000573815.1 linkn.293-7T>A splice_region_variant, intron_variant Intron 3 of 5 5

Frequencies

GnomAD3 genomes
AF:
0.00705
AC:
1073
AN:
152156
Hom.:
9
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00212
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00811
Gnomad ASJ
AF:
0.00749
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00538
Gnomad FIN
AF:
0.00226
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0111
Gnomad OTH
AF:
0.0115
GnomAD2 exomes
AF:
0.00699
AC:
1713
AN:
245130
AF XY:
0.00739
show subpopulations
Gnomad AFR exome
AF:
0.000809
Gnomad AMR exome
AF:
0.00689
Gnomad ASJ exome
AF:
0.00746
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00318
Gnomad NFE exome
AF:
0.0106
Gnomad OTH exome
AF:
0.0104
GnomAD4 exome
AF:
0.00898
AC:
13038
AN:
1452040
Hom.:
73
Cov.:
33
AF XY:
0.00903
AC XY:
6511
AN XY:
721122
show subpopulations
African (AFR)
AF:
0.00175
AC:
58
AN:
33206
American (AMR)
AF:
0.00693
AC:
301
AN:
43462
Ashkenazi Jewish (ASJ)
AF:
0.00831
AC:
213
AN:
25626
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39514
South Asian (SAS)
AF:
0.00412
AC:
353
AN:
85716
European-Finnish (FIN)
AF:
0.00265
AC:
141
AN:
53222
Middle Eastern (MID)
AF:
0.0128
AC:
73
AN:
5702
European-Non Finnish (NFE)
AF:
0.0103
AC:
11382
AN:
1105770
Other (OTH)
AF:
0.00864
AC:
517
AN:
59822
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
643
1286
1929
2572
3215
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
422
844
1266
1688
2110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00705
AC:
1073
AN:
152274
Hom.:
9
Cov.:
32
AF XY:
0.00670
AC XY:
499
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.00212
AC:
88
AN:
41550
American (AMR)
AF:
0.00810
AC:
124
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00749
AC:
26
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00539
AC:
26
AN:
4828
European-Finnish (FIN)
AF:
0.00226
AC:
24
AN:
10628
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.0111
AC:
757
AN:
68006
Other (OTH)
AF:
0.0114
AC:
24
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
56
112
167
223
279
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0101
Hom.:
2
Bravo
AF:
0.00736
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

KIF1C: BP4, BS1, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Jul 06, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Spastic ataxia 2 Benign:1
Jan 11, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary spastic paraplegia Benign:1
Jun 06, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.45
CADD
Benign
5.8
DANN
Benign
0.72
PhyloP100
-0.41
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0020
dbscSNV1_RF
Benign
0.10
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148404628; hg19: chr17-4923780; API